TP53 and colonic neoplasm: In HT29 colon cancer cells, BITC and PEITC have been demonstrated to have anti-metastatic and anti-inflammatory effects against colon cancer, and it slowed the migration of colon cancer cells through the activation of p53 pathway (147, 168, 169).